Maldonado I

No ORCID on file · 1 paper in corpus · active 2022
2022
Human vaccines & immunotherapeutics ·doi:10.1080/21645515.2022.2078626

Among women aged 27-45 years, the quadrivalent human papillomavirus (qHPV; HPV6/11/16/18) vaccine was generally well tolerated, efficacious, and immunogenic in the placebo-controlled FUTURE III study (NCT00090220; n = 3253). The qHPV vaccin…